The choice between gastric sleeve surgery and gastric bypass depends on individual factors. The sleeve is less invasive and focuses solely on restricting stomach size, while the bypass alters both stomach size and digestive processes. Bypass surgery often results in more weight loss but comes with higher risks of malabsorption and complications.

Pregnancy after weight-loss surgery is generally safe, but it’s recommended to wait at least 12-18 months after bariatric surgery before trying to conceive. This waiting period allows the body to stabilize and ensures proper nutrition for both the mother and baby. Women should work closely with their doctors to monitor their nutritional intake and ensure they are getting adequate vitamins and minerals during pregnancy.

Diarrhoea associated with gastritis can occur due to inflammation in the stomach affecting the intestines. This symptom often accompanies nausea, bloating, and abdominal pain. Managing diarrhea involves treating the underlying gastritis, typically with acid-reducing medications and dietary adjustments.

Weight-loss injections such as Saxenda or Wegovy can lead to side effects like nausea, vomiting, diarrhea, constipation, and abdominal pain. In rare cases, patients may experience gallbladder issues or pancreatitis. It’s important to monitor for side effects and adjust dosage as needed under medical supervision.

A weight-loss shot refers to medications like Wegovy (semaglutide), which are injected to aid weight loss. These drugs work by mimicking a hormone that targets areas of the brain responsible for appetite, helping individuals feel full with less food. These injections are typically prescribed for patients with obesity or related health issues.

Gastritis treatment focuses on reducing inflammation in the stomach lining. This may involve antacids, proton pump inhibitors, or antibiotics if caused by H. pylori infection. Lifestyle changes, such as avoiding spicy foods, alcohol, and NSAIDs, can also help manage symptoms.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

The choice between gastric sleeve surgery and gastric bypass depends on individual factors. The sleeve is less invasive and focuses solely on restricting stomach size, while the bypass alters both stomach size and digestive processes. Bypass surgery often results in more weight loss but comes with higher risks of malabsorption and complications.

An abdominal tumor is any abnormal growth located within the abdomen. Tumors can originate from the stomach, intestines, liver, or other abdominal organs. They can be benign or malignant, and treatment often involves surgery, chemotherapy, or radiation therapy, depending on the tumor's size, type, and stage.

Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

After undergoing Roux-en-Y gastric bypass surgery (RNY), the diet is critical for long-term success and recovery. Immediately after surgery, patients are required to follow a liquid diet to allow their stomachs to heal. Over time, they transition from liquids to soft foods, and eventually solid foods. This post-op diet is high in protein to support muscle retention and healing, low in fats and sugars, and carefully portioned to avoid stretching the stomach pouch. Lifelong dietary changes are necessary to avoid... +More

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

Sleeve surgery is another term for the gastric sleeve procedure, where most of the stomach is removed to help patients achieve significant weight loss. The procedure is less invasive than other forms of bariatric surgery, like the Roux-en-Y bypass, but still offers dramatic weight-loss results.

Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.